Hedgehog (Hh) proteins specify tissue pattern in metazoan embryos by forming gradients that emanate from discrete sites of expression and elicit concentration-dependent cellular differentiation or proliferation responses 1,2 . Cellular responses to Hh and the movement of Hh through tissues are both precisely regulated, and abnormal Hh signalling has been implicated in human birth defects and cancer [3] [4] [5] [6] [7] . Hh signalling is mediated by its amino-terminal domain (HhN), which is dually lipidated and secreted as part of a multivalent lipoprotein particle [8] [9] [10] . Reception of the HhN signal is modulated by several cell-surface proteins on responding cells, including Patched (Ptc), Smoothened (Smo) , Ihog (known as CDO or CDON in mammals) and the vertebrate-specific proteins Hip (also known as Hhip) and Gas1 (ref. 11) . Drosophila Ihog and its vertebrate homologues CDO and BOC contain multiple immunoglobulin and fibronectin type III (FNIII) repeats, and the first FNIII repeat of Ihog binds Drosophila HhN in a heparindependent manner 12, 13 . Surprisingly, pull-down experiments suggest that a mammalian Sonic hedgehog N-terminal domain (ShhN) binds a non-orthologous FNIII repeat of CDO 12, 14 . Here we report biochemical, biophysical and X-ray structural studies of a complex between ShhN and the third FNIII repeat of CDO. We show that the ShhN-CDO interaction is completely unlike the HhN-Ihog interaction and requires calcium, which binds at a previously undetected site on ShhN. This site is conserved in nearly all Hh proteins and is a hotspot for mediating interactions between ShhN and CDO, Ptc, Hip and Gas1. Mutations in vertebrate Hh proteins causing holoprosencephaly and brachydactyly type A1 map to this calcium-binding site and disrupt interactions with these partners.
CDO is composed of five immunoglobulin domains followed by three FNIII repeats, a membrane-spanning region and a cytoplasmic tail 15 . The second FNIII repeat of CDO (CDOFn2) is homologous to the Ihog repeat that binds Drosophila HhN and heparin, but the third FNIII repeat (CDOFn3) seems to be most important for binding Shh 12, 14 (Figs 1a and 2a ). However, purified CDOFn2, CDOFn3 and a tandem repeat of these domains (CDOFn23) all failed to interact appreciably with ShhN in the presence or absence of heparin, as judged by size-exclusion chromatography (SEC). Pull-down experiments showing an interaction between ShhN and CDOFn3 were performed in the presence of serum 12, 14 , and a search for additional factors involved in ShhN-CDO binding led to the discovery that calcium ions promote high-affinity interactions between ShhN and CDOFn3 ( Supplementary Fig. 1 ). Analytical ultracentrifugation and isothermal titration calorimetry (ITC) studies demonstrate that the interaction between ShhN and CDOFn3 is 1:1, requires calcium, is not heparin-dependent, and has a dissociation constant of ,1.3 mM (Figs 1a and 2c, and Supplementary Fig. 2 ).
The calcium-dependent ShhN-CDOFn3 complex was crystallized, and its structure determined by molecular replacement and refined to R/R free of 0.186/0.229 at 1.7 Å resolution (Supplementary Table 1 ). The ShhN-CDOFn3 interface buries 1,325 Å 2 with a shape complementarity of 0.61 ( Fig. 1b, c )-values consistent with a physiological interface 16, 17 Fig. 1c and Supplementary . Binding studies with four previously created clusters of surface mutations in ShhN (surfaces A, B, C and D) 12 and five new mutations support identification of this interface as functionally relevant ( Supplementary Fig. 3 ). Sequence analysis suggests that BOC, a receptor for Shh in axon guidance 18 , is likely to bind ShhN in the same manner as CDO ( Supplementary Figs 5 and 6 ).
The structure of the ShhN-CDOFn3 complex reveals a previously unknown binuclear calcium-binding site in ShhN buried at the interface with CDOFn3, which accounts for the calcium-dependence of this interaction (Fig. 1) . The calcium ions are coordinated by three aspartate and three glutamate residues in ShhN (Asp 96, Asp 130, Asp 132, Glu 90, Glu 91 and Glu 127) in an arrangement similar to binuclear calcium sites in other proteins 19 . Each ion is coordinated by eight oxygen atoms with an average distance of 2.5 Å , consistent with calcium coordination 20 . Identification of these ions as calcium was confirmed by anomalous difference Fourier analysis ( Supplementary  Fig. 7 ). The level of conservation of the six calcium-coordinating residues in Hh sequences suggests that calcium binding is a general property of Hh proteins ( Supplementary Fig. 8 ). Attempts to measure the dissociation constant of ShhN for calcium indicate a K d of .100 mM. This weak affinity explains the failure to observe this calcium site in earlier HhN crystal structures, as calcium would have dissociated during purification 13, 21 . One millimolar Ca 21 is sufficient to restore calcium-dependent activity to ShhN in vitro, and the presence of ,1 mM calcium ions in the extracellular space suggests that calcium is likely to be a constitutive component of HhN proteins in vivo.
Notably, the ShhN-CDOFn3 interaction is completely unlike the interaction between Drosophila HhN and Ihog 13 (Fig. 2b) . The surfaces on ShhN and HhN that bind CDO and Ihog, respectively, overlap at only a single residue and interact with non-orthologous domains of CDO and Ihog (CDOFn3 versus IhogFn1). This result is surprising given the 68% sequence identity between human SHHN and Drosophila HhN and sequence and functional data implicating CDO and BOC as the closest vertebrate homologues of Ihog 12, 14, 22 . To confirm the distinct binding modes, four simultaneous amino acid substitutions (T41Y, A44V, Y45L and K179R) were introduced into ShhN to create a variant, ShhN-Fly, that contains all Ihog-contacting residues found at the Drosophila HhN-Ihog interface 13 . ShhN-Fly binds Ihog with 100-fold greater affinity than wild-type ShhN and has a slightly stronger affinity for Ihog (K d of ,0.5 mM) than does Drosophila HhN (K d of ,2.6 mM; Fig. 2c, d ). ShhN-Fly does not bind well to cells expressing Drosophila Ptc ( Supplementary Fig. 9 ). As is the case for HhN, ShhN-Fly requires heparin but not calcium to bind Ihog, and the interaction is exothermic (Fig. 2c, d) . In contrast, the interaction between ShhN or ShhN-Fly and CDO is endothermic ( Fig. 2c and Supplementary Fig. 10 ). Expression of Shh-Fly within clones in the anterior compartment of Drosophila wing imaginal discs also induces expression of the Hh pathway target gene ptc to a greater extent than wild-type Shh, and this expression extends several cells beyond the clone boundary ( Supplementary Fig. 11 ).
Although modelling suggests that a complex containing ShhN-Fly, IhogFn12 and CDOFn3 is possible, this complex is not observed by SEC. The CDO-binding site on ShhN overlaps extensively with a heparin-binding site required for interactions between HhN and Ihog 13 , and heparin may impede binding of CDOFn3 to ShhN-Fly. Analysis of Hh sequences suggests that the CDO-like binding mode is conserved in vertebrates and the Ihog-like mode in arthropods, but the binding mode for intermediate and earlier branchpoint clades is not clear.
Given the importance of this previously unappreciated calciumbinding site for Shh-CDO interactions, we examined its role in mediating interactions between ShhN and other ShhN-binding partners. Four simultaneous amino-acid substitutions in the ShhN calciumbinding site (E90Q, E91Q, E127Q and D132N) or an increase in concentration of EGTA, a calcium chelator, led to a .10-fold reduction in ShhN binding to Hip-transfected cells and a ,2-fold reduction in binding to Ptc-transfected cells when compared to wild-type ShhN (Fig. 3a, b ). EGTA also reduces binding of Drosophila HhN to Drosophila Ptc-transfected cells ( Supplementary Fig. 12 ). The effects of EGTA seem stronger, possibly owing to effects of calcium chelation on the cell membrane or chelation of a previously identified zinc ion in ShhN 21 . The presence of increasing amounts of soluble CDOFn3 or CDOFn23, but not CDOFn2, also reduced the ability of ShhN to bind to Hip-and Ptc-transfected cells of human or fly origin ( Fig. 3c and Supplementary Figs 13 and 14 ), suggesting that Hip and Ptc may compete directly with CDO for binding to ShhN. Although consistent with our results, direct competition would conflict with an earlier observation of synergy between CDO and Ptc for Shh binding 23 . Resolution of this issue awaits studies with purified proteins.
Gas1 has also been reported to interact with Shh 23 , and a pulldown assay was developed in which Fc-tagged Gas1 immobilized on protein G beads was used to precipitate ShhN. The absence of calcium in the precipitating medium or the presence of CDOFn3 (but not CDOFn2) greatly reduced the ability of Gas1 to precipitate ShhN ( Fig. 3d, e ). These results suggest that an intact and accessible calcium-binding site on ShhN is required to mediate interactions between ShhN and Gas1.
A missense substitution in human SHH (D88V) that causes holoprosencephaly (HPE) 24 , a developmental disorder involving abnormal formation of midline face and forebrain features, maps to a loop on ShhN that contains three of the six calcium-coordinating residues (Fig. 4a ). Asp 88 does not directly contact CDOFn3 or coordinate calcium but stabilizes the conformation of the calcium-coordinating loop by forming hydrogen bonds to two backbone amides. Introduction of the D88V substitution into ShhN results in loss of detectable binding to CDOFn3 (Fig. 4b ) and reduces binding of ShhN to Hip-expressing cells by ,4-fold and to Ptc-expressing cells by ,5-fold ( Fig. 4d ). ShhN(D88V) also binds less well to Gas1 ( Supplementary Fig. 15 ). Although no molecular explanation for the effects of the D88V mutation was previously apparent, it is now clear that the D88V reduces the affinity of ShhN for multiple partners through disruption of the calcium-coordinating region. Brachydactyly type A1 (BDA1) is characterized by absent or shortened middle phalanges 5 . Five missense substitutions in human Indian hedgehog (IHH) that cause BDA1 (E95K, E95G, D100N, D100E and E131K) affect residues that directly coordinate calcium (Fig. 4a) . ITC experiments show that wild-type IHH binds CDOFn3 with a K d of ,2.7 mM in the presence of calcium ( Supplementary Fig. 16 ), similar to the value of 1.3 mM for ShhN binding to CDOFn3. Introduction of the E131K mutation into IHHN results in loss of detectable CDOFn3 binding (Fig. 4c ), and the E131K and D100E substitutions reduce binding of IHH to cells expressing Ptc by ,4-fold and 10-fold, respectively (Fig. 4e) . The E131K and D100E substitutions also reduced IHH binding to Hip-expressing cells .20-fold (Fig. 4e) ; the presence of EGTA decreased binding of wild-type IHH to Ptc-and Hip-expressing cells by similar amounts ( Supplementary Fig. 17 ), implicating disruption of calcium-dependent interactions as a common mechanism for BDA1-causing substitutions. The a, Cells expressing Hip or Ptc were assayed for Shh binding in the presence of 1.8 mM Ca 21 (black bars) and increasing EGTA concentrations (1.8-2.7 mM, white bars). b, Cell-based binding assays were performed with wildtype Shh and a Shh calcium-binding-site mutant (Ca mutant) in the presence of calcium. c, Cell-based binding assays with wild-type Shh were performed in the presence of calcium (black bars) and 0.5-30 mM soluble CDOFn2 (grey bars) or CDOFn3 (white bars). Error bars in a-c indicate standard deviation, with n 5 3. d, Gas1 Fc-fusion protein was immobilized to protein G beads, and binding to ShhN was assayed by a western blot in the presence and absence of calcium. e, Gas1 pull-down experiments were repeated in the presence of CDOFn3 or CDOFn2. NATURE | Vol 455 | 16 October 2008 Fig. 15 ), and substitutions in Shh equivalent to each of the five IHH BDA mutations reduced binding of Shh to Hip and Ptc in cell-based assays ( Supplementary Fig. 18 ).
Ptc, CDO and Gas1 are positive regulators of Hh signalling 25 , and Hip is a negative regulator 26 . The BDA1-causing Ihh mutations act in a dominant, gain-of-function manner 3 , and produce a phenotype resembling a dominant mutation that produces ectopic expression of the Shh gene within the developing digits 27 . Among the complex effects of BDA1 mutations, disruption of interactions with Hip and an increased range of signalling seem most likely to cause a gain-offunction phenotype. Indeed, introduction of the E95K substitution into mouse Ihh (Glu 91 in mouse Shh) increases the range of Ihh action within the digit primordia of the limb, albeit with a reduced signalling potency (D. Chan et al., personal communication). In contrast, the loss-of-function phenotype of the D88V mutation in Shh suggests that effects of this mutation on interactions with Ptc, CDO and/or Gas1 predominate. In general, the phenotype produced by calcium-site mutations is likely to be a composite of positive and negative effects depending on the importance or expression of various partners in affected tissues and processes.
We have shown that vertebrate Hh proteins use a previously unappreciated binuclear calcium-binding site to mediate interactions with multiple partners. Mutations causing the developmental disorders HPE and BDA1 map to this region in Shh and Ihh, respectively. Surprisingly, structural and biochemical studies demonstrate that vertebrate Hh proteins interact with the adhesion-like molecule CDO in a completely different manner than the homologous HhN-Ihog pair in Drosophila 13 . This difference may have arisen through convergent evolution, in which vertebrate and invertebrate ancestors independently evolved the use of homologous molecules to modulate Hh signalling. We find this scenario unlikely and suggest the following alternative. Hh proteins are secreted as part of a multivalent lipoprotein complex 9, 10 , which must result in high-density clustering of Hh binding partners at a localized patch on the surface of target cells. At sites of high local concentration and reduced dimensionality, weak interactions may become functionally relevant, and single mutations may have profound positive or negative effects 28 . We propose that, after evolution of an Ihog/CDO precursor that mediated Hh binding, clustering may have led to a bimodal interaction between Hh and Ihog/CDO. Additional substitutions could have resulted in the loss of one of the two binding modes in different species. Once different binding modes that supply the same function emerged, evolution of different regulatory mechanisms became possible.
METHODS SUMMARY
Sedimentation velocity experiments. Experiments were conducted at 4 uC on a Beckman Coulter XL-I analytical ultracentrifuge using multiple loading concentrations and rotor speeds of 55,000 or 60,000 r.p.m. (,244,000-290,000g). Scans were analysed in SEDFIT 11.3 to obtain a sedimentation coefficient, s or a c(s) distribution 29 . Values were corrected to 20 uC and water to obtain s 20,w or c(s 20,w ) using solvent parameters calculated in SEDNTERP 1.09. Crystallization. Mouse ShhN (residues 26-189) and human CDOFn3 (826-924) were mixed in the presence of 2 mM CaCl 2 , incubated for 1 h at 22-24 uC, and the ShhN-CDOFn3 complex was purified by SEC and concentrated to ,6 mg ml 21 total protein. The complex was crystallized by vapour diffusion in hanging drops at 20 uC by mixing 1 ml of protein solution with 1 ml of reservoir buffer (28% PEG 3350, 200 mM MgCl 2 , 100 mM Tris, pH 8.3). The complex crystallized in space group C222 1 with unit cell dimensions a 5 71.2, b 5 98.6 and c 5 144.0 Å . ITC experiments. Titrations were performed using a VP-ITC MicroCalorimeter (MicroCal Inc.). When IhogFn1-2 binding was assayed 13 , 300 mM LMW heparin (Sigma) was included. CDO or Ihog proteins (143-432 mM) were added to a 1.38-ml cell containing a specific HhN protein (10-38 mM) while stirring at 260 r.p.m. Data were processed with Origin software and best fit by a single binding site model. Cell-based binding assays. Cos1 cells plated in 6-well plates were transfected with Fugene 6 (Roche) for 48 h followed by incubation with conditioned medium containing ShhN-Ren or IhhN-Ren proteins on ice for 1 h. Cells were washed three times with cold PBS or DMEM, lysed, and 50 ml of lysate was used to measure luciferase activities. 
